Zobrazeno 1 - 10
of 49
pro vyhledávání: '"R J Glynn"'
Autor:
Elisabetta Patorno, Lily G. Bessette, Mehdi Najafzadeh, Deborah J. Wexler, Anouk Deruaz-Luyet, S. Zimner, Helen Tesfaye, L. Koeneman, L.E. Zabotka, Sebastian Schneeweiss, R J Glynn
Publikováno v:
Annales d'Endocrinologie. 82:266-267
Dans EMPA-REG-OUTCOME, l’empagliflozine a reduit le risque de deces CV, deces toutes causes et hospitalisations pour insuffisance cardiaque (hIC) chez les patients DT2 avec maladie CV (MCV) etablie. Nous avons evalue l’efficacite CV d’empaglifl
Population-based studies have suggested that benzodiazepines (BZDs) are associated with an over 3-time increased mortality risk in adults, which may be explained by residual confounding. We assessed the mortality risk associated with BZD initiation i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bfc4d81430cdc28f33ccd4fc67de24c
https://europepmc.org/articles/PMC6230044/
https://europepmc.org/articles/PMC6230044/
Autor:
Jerry Avorn, Kenneth Rockwood, R J Glynn, Sebastian Schneeweiss, Lewis A. Lipsitz, Dae Hyun Kim
Frailty is an important determinant of health outcomes in older adults that is not measured in Medicare data. We recently developed a claims-based frailty index (CFI) to approximate a survey-based deficit-accumulation frailty index. This study aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::980ac2ad313994acc0945772dc251179
https://europepmc.org/articles/PMC6227826/
https://europepmc.org/articles/PMC6227826/
Publikováno v:
Innovation in Aging. 2:853-853
Whether the benefit of dabigatran relative to warfarin is similar in frail and non-frail patients is of great clinical relevance. We conducted a propensity score-matched cohort study of 153,421 Medicare beneficiaries with atrial fibrillation who init
Autor:
Krista F. Huybrechts, Dae Hyun Kim, Sebastian Schneeweiss, Elisabetta Patorno, Julie Barberio, Janet Sultana, R J Glynn
Publikováno v:
Europe PubMed Central
A propensity-score matched cohort study was conducted in two US commercial insurance databases, including 365,816 adults ≥60 years with type 2 diabetes who initiated dipeptidyl peptidase-4 inhibitors (DPP4i) or sulfonylureas. We assessed the risk o
Autor:
R. J. Glynn
Publikováno v:
Archives of Internal Medicine. 155:1855-1860
Autor:
J, Avorn, R J, Glynn, J H, Gurwitz, R L, Bohn, M, Monane, D E, Everitt, D, Gilden, I, Choodnovskiy
Publikováno v:
Journal of glaucoma. 2(3)
We conducted a case-control study to measure the risk of pulmonary side effects following the use of topical glaucoma medications, particularly the beta blockers, and to identify patients at highest risk for such side effects. Patients over age 55 wh
Publikováno v:
Journal of glaucoma. 3(3)
Autor:
W G, Christen, R J, Glynn, U A, Ajani, D A, Schaumberg, J E, Manson, J E, Buring, C H, Hennekens
Publikováno v:
Ophthalmic epidemiology. 7(2)
To examine whether a reported history of cataract, a possible marker of aging, is associated with future mortality.Participants were 18,669 of the 22,071 U.S. male physicians enrolled in the Physicians' Health Study I who had complete information at
Publikováno v:
Journal of epidemiology and biostatistics. 5(2)
Responses to questions on sensitive behaviours can be affected by when and how questions are asked.Using data from an ongoing survey of women taking isotretinoin (a teratogenic drug used to treat acne), we compared answers to questions on contracepti